Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations-Reference-Cited by-同舟云学术

Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations

Published:2014-08-25 Issue:9 Volume:11 Page:8645-8660
ISSN:1660-4601
Container-title:International Journal of Environmental Research and Public Health
language:en
Short-container-title:IJERPH

Author:

Yilmaz Ahmet,Mohamed Nehad,Patterson Kara,Tang Yan,Shilo Konstantin,Villalona-Calero Miguel,Davis Michael,Zhou Xiao-Ping,Frankel Wendy,Otterson Gregory,Zhao Weiqiang

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

http://www.mdpi.com/1660-4601/11/9/8645/pdf

Reference54 articles.

1. Estimating the world cancer burden: Globocan 2000

2. Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics

3. Molecularly targeted drugs for metastatic colorectal cancer;Cheng;Drug Des. Dev. Ther.,2013

4. EGFR and KRAS mutations, and ALKfusions: Current developments and personalized therapies for patients with advanced non-small-cell lung cancer;De Mello;Pharmacogenomics,2013

5. KRAS Mutations in Non-Small Cell Lung Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung);Journal of Translational Medicine;2024-07-31

2. A lung cancer risk prediction model for nonsmokers: A retrospective analysis of lung nodule cohorts in China;Journal of Clinical Laboratory Analysis;2022-11

3. Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers;Cancers;2022-08-24

4. KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location;Pathology & Oncology Research;2020-06-27

5. RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies;Critical Reviews in Oncology/Hematology;2020-02